[What can thoracic surgery accomplish in recurrent/second carcinoma of non-small-cell bronchial carcinoma?].
From 1990 to 2000, 2268 (29.9%) of 9600 lung cancer patients underwent resection for stage I to IIIA non-small cell lung cancer. Reinterventions were done in one hundred (3.5%) patients, for locoregional recurrence in 27, metachronous cancer in 42, metastasis or a third tumor in 31. A third intervention was performed in 23 patients and a fourth in two. The in-hospital mortality rate was 9%. The overall survival was 31.9% at five and 17.9% at ten years. The 5-year survival after the first intervention (reintervention) was 26% (11%) for local recurrence, 80.3% (27%) for metachronous cancer, 7% (0%) for recurrence of synchronous cancers and 0% (0%) for lung metastasis after a solitary primary lung cancer.
Wex
P
P
Klinik für Thorax- und Gefässchirurgie, Klinik Löwenstein, Zentrum für Pneumologie, Thorax- und Gefässchirurgie, 74245 Löwenstein.
Utta
E
E
Haas
V
V
D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D005500:Follow-Up Studies; D017052:Hospital Mortality; D006801:Humans; D008168:Lung / Q000473:pathology; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000556:secondary / Q000601:surgery*; D009367:Neoplasm Staging; D009378:Neoplasms, Multiple Primary / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D016609:Neoplasms, Second Primary / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D011013:Pneumonectomy; D011183:Postoperative Complications / Q000401:mortality; D012086:Reoperation; D015996:Survival Rate
Was kann die Thoraxchirurgie beim Rezidiv-/Zweitcarcinom des nicht kleinzelligen Bronchialcarcinoms leisten?